Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Lipid imbalance triggered by Snail-driven epithelial–mesenchymal transition creates a cholesterol-dependent vulnerability that can be therapeutically targeted to overcome chemoresistance in cancer.
Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune ...
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Women who received Elenagen plus chemotherapy lived significantly longer than those who received chemotherapy alone.
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.
A shift in the balance between two lipids – cholesterol and sphingomyelin – makes hybrid epithelial-mesenchymal cancer cells less responsive to certain chemotherapy drugs.
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.
Jan 22 (Reuters) - Corcept Therapeutics said on Thursday a late-stage trial showed its experimental drug in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results